Skip Navigation

Cardiovascular Research 2002 53(2):392-404; doi:10.1016/S0008-6363(01)00490-4
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nikolaidis, L. A
Right arrow Articles by Shannon, R. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nikolaidis, L. A
Right arrow Articles by Shannon, R. P
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

Catecholamine stimulation is associated with impaired myocardial O2 utilization in heart failure

Lazaros A Nikolaidisa, Teresa Hentosza, Aaron Doverspikea, Rhonda Huerbina, Carol Stolarskia, You-Tang Shenb and Richard P Shannona,*

aDepartment of Medicine, Allegheny General Hospital, MCP-Hahneman University School of Medicine, 320 E. North Avenue, Pittsburgh, PA 15212, USA
bMerck Research Laboratories, West Point, PA, USA

* Corresponding author. Tel.: +1-412-359-3022; fax: +1-412-359-8152 rshannon{at}wpahs.org

Objectives: To investigate the effect of {alpha}, β1 and β2 adrenergic receptor (AR) stimulation on coronary hemodynamics, myocardial oxygen consumption (MvO2) and metabolic substrate preference in advanced dilated cardiomyopathy (DCM). Methods: We studied 19 conscious, instrumented dogs with pacing-induced DCM. We evaluated systemic, coronary hemodynamics and MvO2 in response to norepinephrine (NOR, 0.05–0.4 µg/kg per min), dobutamine (DOB, 1–10 µg/kg per min), phenylephrine (PHE, 1–5 µg/kg per min) and isoproterenol (ISO, 0.05–0.4 µg/kg per min) alone or in the presence of metoprolol (ISO+MET). Experiments were conducted in control state and in advanced DCM, 4–5 weeks after the initiation of pacing. Results: Contractile responses (LV dP/dt) to catecholamines were desensitized and accompanied by a parallel decrease in heart rate-adjusted myocardial O2 consumption (MvO2/beat), when {alpha} (PHE) or β1 (DOB) or both {alpha}1 (NOR) AR were stimulated in DCM. This was due to impaired transmyocardial (Ao–Cs) O2 extraction rather than limitations in CBF responses. There was an associated shift in myocardial metabolism, evidenced by an increased preference for glycolytic substrates ({uparrow}Respiratory Quotient) following administration of any of these three adrenergic agonists in DCM. Combined β12 stimulation with ISO or β2-AR stimulation (ISO+MET) in DCM resulted in greater MvO2/beat, [(Ao–Cs) O2] extraction, and decreases in myocardial RQ consistent with a shift toward oxidation of FFA. Conclusions: The impairment in contractile responses to dobutamine and norepinephrine in DCM is associated with impaired myocardial O2 extraction, and a shift toward a preference for glycolysis. A different myocardial metabolic pattern suggestive of increased oxidation of FFA with increased myocardial O2 extraction was observed in the presence of combined β12 stimulation with isoproterenol or β2 stimulation (ISO+MET). These data suggest that β2-AR stimulation in DCM shifts substrate preference toward FFA oxidation associated with greater MvO2 requirements. These findings identify a putative metabolic effect of β2 –AR in DCM that may be deleterious.

KEYWORDS Cardiomyopathy; Adrenergic (ant)agonists; Heart failure; Oxygen consumption; Energy metabolism; Hemodynamics


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
G. D. Lopaschuk
Optimizing cardiac Fatty Acid and glucose metabolism as an approach to treating heart failure.
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 228 - 230.
[Abstract] [PDF]


Home page
Physiol. Rev.Home page
W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk
Myocardial Substrate Metabolism in the Normal and Failing Heart
Physiol Rev, July 1, 2005; 85(3): 1093 - 1129.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
S. J. Davies and R. J. T. Wilson
Preoperative optimization of the high-risk surgical patient
Br. J. Anaesth., July 1, 2004; 93(1): 121 - 128.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. A Nikolaidis, A. Sturzu, C. Stolarski, D. Elahi, Y.-T. Shen, and R. P Shannon
The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy
Cardiovasc Res, February 1, 2004; 61(2): 297 - 306.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
I. P. Uray, J. H. Connelly, O.H. Frazier, H. Taegtmeyer, and P. J.A. Davies
Mechanical unloading increases caveolin expression in the failing human heart
Cardiovasc Res, July 1, 2003; 59(1): 57 - 66.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.